Omada Health (OMDA) vs Pennant Group (PNTG)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Pennant Group (PNTG) has outperformed Omada Health (OMDA) over the past year, gaining 29.9% versus a loss of 36.2%. Pennant Group is the larger company by market cap ($1.22 billion vs $736.4 million), about 1.7 times the size, while Omada Health is growing revenue faster (+53.2% vs +36.3%). On valuation, Omada Health trades at a lower forward P/E (17.2x vs 22.0x for Pennant Group).
Pennant Group converts more of its revenue into profit, with a net margin of 3.1% versus -4.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | OMDA | PNTG |
|---|---|---|
| Share price | $11.87 | $34.64 |
| Market cap | $736.39M | $1.22B |
| 1-day change | -5.04% | +1.61% |
| YTD return | -24.78% | +23.06% |
| 1-year return | -36.18% | +29.88% |
| 5-year return | — | +69.39% |
| P/E ratio (TTM) | 29.68 | 34.30 |
| Forward P/E | 17.18 | 22.00 |
| EPS (TTM) | $0.40 | $1.01 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $260.21M | $947.71M |
| Revenue growth (YoY) | +53.24% | +36.31% |
| Net income (latest FY) | $-12.78M | $29.58M |
| Gross margin | 65.69% | 18.91% |
| Operating margin | -4.60% | 5.47% |
| Net margin | -4.91% | 3.12% |
| 52-week high | $25.45 | $44.24 |
| 52-week low | $10.28 | $26.40 |
| Distance from 52-week high | -53.36% | -21.70% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +123.25% | +38.57% |
| Average volume | 1.33M | 391.52K |
| Shares outstanding | 62.04M | 35.13M |
| Employees | 980 | 9,700 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- PNTG has outperformed OMDA by 66.1 percentage points over the past year.
- Pennant Group is more profitable, keeping 3.1 cents of every revenue dollar as net income versus -4.9 cents for Omada Health.
- Omada Health grew revenue faster in its latest fiscal year (+53.24% vs +36.31%).
About Omada Health
OMDA stock →Omada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs.
Health Care · Medical/Nursing Services · 980 employees
About Pennant Group
PNTG stock →The Pennant Group, Inc. provides healthcare services in the United States.
Health Care · Medical/Nursing Services · 9,700 employees
OMDA vs PNTG FAQ
Which is bigger, Omada Health or Pennant Group?
Pennant Group (PNTG) is larger, with a market capitalization of $1.22B compared with $736.39M for Omada Health (OMDA).
Which stock has performed better over the past year, OMDA or PNTG?
PNTG returned +29.88% over the past 12 months, compared with -36.18% for OMDA (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, OMDA or PNTG?
OMDA has the lower trailing P/E at 29.7, versus 34.3 for PNTG. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Omada Health and Pennant Group in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.